Home›Companies›Biotech & Pharma›Heligenics

Heligenics, Inc.

Updated Oct 27, 2026·Latest SEC filing Jan 8, 2025·Suggest an edit

About Heligenics

Heligenics is a private company based in Las Vegas, Nevada. It has reported $5,971,775 raised in three offerings on Form D since December 2020.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 23, 2024Jan 8, 2025$2,631,775fully sold8$328KEquityRule 506(b)Form D ↗
Jun 9, 2022Aug 23, 2022$2,160,000fully sold12$180KEquityRule 506(b)Form D ↗
Mar 31, 2020Dec 16, 2020$1,180,000of $2.4M target39$30,256EquityRule 506(b)Form D ↗
Total, three offerings$5,971,775

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Heligenics's Form D filed Jan 8, 2025.

MS
Martin Schiller
Executive officer

Earlier filings also listed Lawrence Loomis (chief operating office & corporate secretary, director, last listed Dec 2020).

Sources

  1. SECHeligenics, Inc. filing history